reglab/housing_qa huggingface dataset:
DC Code § 7-1402 (2021)
2021 District of Columbia Code|Title 7 - Human Health Care and Safety|Chapter 14 - Health Care Safety Net Administration|§ 7-1402. Transfers

(a) The functions, real and personal property, personnel, unexpended balances of appropriations, and records of the Public Benefit Corporation shall be transferred to the Department of Health. (b) Any monies remaining in the Health and Hospitals Public Benefit Corporation Fund after July 12, 2001, shall revert to the General Fund to the credit of the Department of Health. (c) The Department of Health shall recognize collective bargaining representatives that have been duly certified by the District of Columbia Public Employees Relations Board and shall assume and be bound by all existing collective bargaining agreements entered into by the Public Benefit Corporation. (d) Every employee of the Public Benefit Corporation shall be transferred to the Department of Health. All employees so transferred shall be under the direction and control of the Director of the Department of Health or that director’s designee or designees. Transferred employees shall retain the same rights and privileges that they had as employees of the Public Benefit Corporation before July 12, 2001, and shall not obtain any additional rights or privileges as a result of the transfer. They shall have all the duties and responsibilities that they had as employees of the Public Benefit Corporation in addition to whatever duties and responsibilities they acquire as employees of the Department of Health. Transferred employees shall constitute a separate competitive area within the Department of Health for purposes of reductions in force only pursuant to § 1-624.08, and Chapter 24 of the District of Columbia Personnel Manual. Lesser competitive areas may be established by the personnel authority for these employees. The Mayor shall be the personnel authority for all employees of the Public Benefit Corporation who are transferred to the Department of Health, except that the personnel authority for accounting, budget, and financial management personnel who are transferred shall continue to be the Chief Financial Officer of the District of Columbia.  (July 12, 2001, D.C. Law 14-18, § 4, 48 DCR 4047.)
DC Code § 7-1403 (2021)
2021 District of Columbia Code|Title 7 - Human Health Care and Safety|Chapter 14 - Health Care Safety Net Administration|§ 7-1403. Liabilities of the Public Benefit Corporation

All liabilities of the Public Benefit Corporation shall be assumed by the District of Columbia.  (July 12, 2001, D.C. Law 14-18, § 5, 48 DCR 4047.)  Section References This section is referenced in § 7-1401.
DC Code § 7-1404 (2021)
2021 District of Columbia Code|Title 7 - Human Health Care and Safety|Chapter 14 - Health Care Safety Net Administration|§ 7-1404. Health Care Safety Net Fund and Appropriations. [Repealed]

Repealed.  (July 12, 2001, D.C. Law 14-18, § 6, 48 DCR 4047; Sept. 24, 2010, D.C. Law 18-223, § 5072(b), 57 DCR 6242; Sept. 14, 2011, D.C. Law 19-21, § 9080, 58 DCR 6226.)  Emergency Legislation For temporary (90 day) amendment of section, see § 5072(b) of Fiscal Year 2011 Budget Support Emergency Act of 2010 (D.C. Act 18-463, July 2, 2010, 57 DCR 6542).
DC Code § 7-1406 (2021)
2021 District of Columbia Code|Title 7 - Human Health Care and Safety|Chapter 14 - Health Care Safety Net Administration|§ 7-1406. Rules

The Mayor, pursuant to subchapter I of Chapter 5 of Title 2, may issue rules to implement the provisions of this chapter. The proposed rules shall be submitted to the Council for a 30-day period of review, excluding Saturdays, Sundays, legal holidays, and days of Council recess. If the Council does not approve or disapprove the proposed rules, in whole or in part, by act within the 30-day period, the proposed rules shall be deemed disapproved.  (July 12, 2001, D.C. Law 14-18, § 7a; as added Mar. 30, 2004, D.C. Law 15-109, § 2, 51 DCR 1342.)  Prior Codifications 2001 Ed., § 7-1405.01. Emergency Legislation For temporary (90 day) addition, see § 2 of Health Care Privatization Rulemaking Emergency Amendment Act of 2003 (D.C. Act 15-126, July 29, 2003, 50 DCR 6831). For temporary (90 day) addition, see § 2 of Health Care Privatization Rulemaking Congressional Review Emergency Amendment Act of 2003 (D.C. Act 15-213, November 7, 2003, 50 DCR 10009). For temporary (90 day) addition, see § 2 of Health Care Privatization Rulemaking Congressional Review Emergency Amendment Act of 2004 (D.C. Act 15-326, January 28, 2004, 51 DCR 1593). Temporary Legislation For temporary (225 day) addition, see § 2 of Health Care Privatization Rulemaking Temporary Amendment Act of 2003 (D.C. Law 15-54, December 9, 2003, law notification 51 DCR 1789). Delegation of Authority Delegation of Authority pursuant to D.C. Law 14-18, the “Health Care Privatization Amendment Act of 2001”, see Mayor’s Order 2004-127, August 2, 2004 ( 51 DCR 8008). Resolutions Resolution 16-607, the “Health Care Safety Net Administration Rulemaking Amendments Emergency Approval Resolution of 2006”, was approved effective April 4, 2006. Resolution 18-149, the “Eligibility Criteria Amendment for the HealthCare Alliance Program Approval Resolution of 2009”, was approved effective June 2, 2009. Resolution 18-343, the “Residency Criteria Amendment for the HealthCare Alliance Program Approval Resolution of 2009”, was approved effective December 15, 2009.
DC Code § 7-1408 (2021)
2021 District of Columbia Code|Title 7 - Human Health Care and Safety|Chapter 14 - Health Care Safety Net Administration|§ 7-1408. Special certification and recertification procedures for certain individuals

Upon request from an applicant or enrollee who is hospitalized, disabled, elderly, or caring for a household member who is hospitalized, disabled, or elderly, the Mayor shall exempt the applicant or enrollee from any required face-to-face interview if the applicant or enrollee is unable to complete a face-to-face interview.  (July 12, 2001, D.C. Law 14-18, § 7c; as added Dec. 13, 2017, D.C. Law 22-35, § 2, 64 DCR 10929; Mar. 16, 2021, D.C. Law 23-251, § 201(a), 68 DCR 001234.)  Applicability Applicability of D.C. Law 23-251: § 401 of D.C. Law 23-251 provided that the repeal of this section by § 201(a) of D.C. Law 23-251 is subject to the inclusion of the law’s fiscal effect in an approved budget and financial plan. Therefore that amendment has not been implemented. Section 5023 of D.C. Law 22-168 amended section 3(a) of D.C. Law 22-35 removing the applicability provision restricting this section. Therefore, the creation of this section by section 2 of Law 22-35 has been implemented.  Applicability of D.C. Law 22-35: § 3 of D.C. Law 22-35 provided that the creation of this section by § 2 of D.C. Law 22-35 is subject to the inclusion of the law’s fiscal effect in an approved budget and financial plan. Therefore that amendment has not been implemented. Emergency Legislation  For temporary (90 days) repeal of this section, see § 2(a) of Department of Health Care Finance Alliance Reform and Budget Transparency Emergency Amendment Act of 2021 (D.C. Act 24-6, Jan. 29, 2021, 68 DCR 001539).
DC Code § 7-1410 (2021)
2021 District of Columbia Code|Title 7 - Human Health Care and Safety|Chapter 14 - Health Care Safety Net Administration|§ 7-1410. DC HealthCare Alliance application and recertification process. [Repealed]

 *NOTE: This section has been amended by emergency legislation with identical permanent legislation that will become effective in January, 2022.*  Repealed.  (July 12, 2001, D.C. Law 14-18; as added Mar. 16, 2021, D.C. Law 23-251, § 201(b), 68 DCR 001234; Aug. 23, 2021, D.C. Act 24-159, § 5112(b), 68 DCR 008602.)  Applicability Applicability of D.C. Law 23-251: § 401 of D.C. Law 23-251 provided that the creation of this section by § 201(b) of D.C. Law 23-251 is subject to the inclusion of the law’s fiscal effect in an approved budget and financial plan. Therefore that amendment has not been implemented. Emergency Legislation  For temporary (90 days) amendment of this section, see § 5112(b) of Fiscal Year 2022 Budget Support Emergency Act of 2021 (D.C. Act 24-159, Aug. 23, 2021, 68 DCR 008602).   For temporary (90 days) amendment of this section, see § 2(b) of Department of Health Care Finance Alliance Reform and Budget Transparency Emergency Amendment Act of 2021 (D.C. Act 24-6, Jan. 29, 2021, 68 DCR 001539).
DC Code § 7-1651.01 (2021)
2021 District of Columbia Code|Title 7 - Human Health Care and Safety|Chapter 16A - Human Papillomavirus Vaccination|§ 7-1651.01. Definitions

For the purposes of this chapter, the term: (1) “CDC” means the Centers for Disease Control and Prevention. (2) “HPV” means the human papillomavirus.  (July 12, 2007, D.C. Law 17-10, § 2, 54 DCR 5146.)
DC Code § 7-1651.02 (2021)
2021 District of Columbia Code|Title 7 - Human Health Care and Safety|Chapter 16A - Human Papillomavirus Vaccination|§ 7-1651.02. Human papillomavirus public education campaign

By January 1, 2008, the Mayor shall initiate a public information campaign, including multiple HPV vaccine education forums in each ward, aimed at educating the public on: (1) The connection between HPV and cervical cancer; (2) The importance of protecting oneself against HPV infection; (3) The value of screening for cervical cancer through regular pap tests; and (4) The effectiveness and risks of the HPV vaccine.  (July 12, 2007, D.C. Law 17-10, § 3, 54 DCR 5146.)
DC Code § 7-1651.03 (2021)
2021 District of Columbia Code|Title 7 - Human Health Care and Safety|Chapter 16A - Human Papillomavirus Vaccination|§ 7-1651.03. Department of Health certification

Within 30 days of the implementation of the HPV vaccination program, the Director of the Department of Health shall provide written certification to the Council that the vaccine is safe and efficacious.  (July 12, 2007, D.C. Law 17-10, § 4, 54 DCR 5146.)
DC Code § 7-1651.04 (2021)
2021 District of Columbia Code|Title 7 - Human Health Care and Safety|Chapter 16A - Human Papillomavirus Vaccination|§ 7-1651.04. Human papillomavirus vaccination program

(a) The Mayor shall: (1) By January 1, 2009, consistent with the standards set forth by the federal Centers for Disease Control and Prevention (“CDC”), establish and implement a HPV vaccination program that includes a requirement that the Department of Health disseminate to all parents or legal guardians information about HPV, including the benefits and risks of the HPV vaccine; (2) Require all communications from the Department of Health on the HPV vaccination program to prominently feature information pertaining to the ability of parents or guardians to opt out of the program; (3) Extend, by rulemaking, the HPV vaccination program requirements to males, consistent with standards set forth by the CDC; and (4) Require the Department of Health to develop reporting requirements for the collection and analyzation of HPV vaccination data. (b)(1) By the beginning of the 2009 school year, and of every school year thereafter, the parent or legal guardian of a female child enrolling in grade 6 for the first time at a school in the District of Columbia shall be required to submit certification: (A) That the child has received the HPV vaccine; or (B) That the child has not received the HPV vaccine because: (i) The parent or legal guardian has objected in good faith and in writing to the chief official of the school that the vaccination would violate his or her religious beliefs; (ii) The child’s private physician, his or her representative, or the public health authority has provided the school written certification that the vaccination is medically inadvisable; or (iii) The parent or legal guardian, in his or her discretion, has elected to opt out of the HPV vaccination program, for any reason, by signing a form prepared by the Department of Health that states the parent or legal guardian has been informed of the HPV vaccination requirement and has elected not to participate. (2) The form, provided pursuant to paragraph (1)(B)(iii) of this subsection, shall include the parent or legal guardian’s name, address, and telephone number and the name of the child. The form shall be available in English, Spanish, and any other language that the Mayor considers culturally appropriate.  (July 12, 2007, D.C. Law 17-10, § 5, 54 DCR 5146.)
DC Code § 7-1651.05 (2021)
2021 District of Columbia Code|Title 7 - Human Health Care and Safety|Chapter 16A - Human Papillomavirus Vaccination|§ 7-1651.05. Rules

The Mayor, pursuant to subchapter I of Chapter 5 of Title 2, shall issue rules to implement the provisions of this chapter.  (July 12, 2007, D.C. Law 17-10, § 6, 54 DCR 5146.)
DC Code § 7-1651.06 (2021)
2021 District of Columbia Code|Title 7 - Human Health Care and Safety|Chapter 16A - Human Papillomavirus Vaccination|§ 7-1651.06. Applicability. [Repealed]

Repealed.  (July 12, 2007, D.C. Law 17-10, § 7, 54 DCR 5146; Aug. 16, 2008, D.C. Law 17-219, § 7089, 55 DCR 7598.)
DC Code § 7-1671.04 (2021)
2021 District of Columbia Code|Title 7 - Human Health Care and Safety|Chapter 16B - Use of Marijuana for Medical Treatment|§ 7-1671.04. Recommending authorize practitioner; protections

(a) An authorized practitioner may recommend the use of medical marijuana to a qualifying patient if the authorized practitioner: (1) Is in a bona fide relationship with the qualifying patient; and (2) Makes the recommendation based upon the authorized practitioner's assessment of the qualifying patient’s medical or dental history, current medical or dental condition, and a review of other approved medications and treatments that might provide the qualifying patient with relief from a qualifying medical or dental condition or the side effects of a qualifying medical or dental treatment. (b)(1) An authorized practitioner's recommendation that a qualifying patient may use medical marijuana shall be signed by the authorized practitioner and include: (A) The authorized practitioner's board-issued license number; and (B) A statement that the use of medical marijuana is necessary for the treatment of a qualifying medical or dental condition or the side effects of a qualifying medical or dental treatment. (2) An authorized practitioner's recommendation shall be valid only if it is written on a form prescribed by ABRA. (c) Except as provided in § 7-1671.07, a physician [an authorized practitioner] shall not be subject to any penalty, including arrest, prosecution, or disciplinary proceeding, or denial of any right or privilege, for advising a qualifying patient about the use of medical marijuana or recommending the use of medical marijuana to a qualifying patient pursuant to this chapter and the rules issued pursuant to § 7-1671.13. (d) An authorized practitioner recommending the use of medical marijuana by a qualifying patient shall not have a professional office located at a dispensary, cultivation center, or testing laboratory or receive financial compensation from a dispensary, cultivation center, or testing laboratory, or a director, officer, member, incorporator, agent, or employee of a dispensary, cultivation center, or testing laboratory.  (Feb. 25, 2010, D.C. Law 13-315, § 5; as added July 27, 2010, D.C. Law 18-210, § 2, 57 DCR 4798; Feb. 18, 2017, D.C. Law 21-209, § 2(d), 63 DCR 15291; Dec. 3, 2020, D.C. Law 23-149, § 5012(c), 67 DCR 10493.)  Section References This section is referenced in § 3-1202.03 and § 7-1671.02.
DC Code § 7-1671.07 (2021)
2021 District of Columbia Code|Title 7 - Human Health Care and Safety|Chapter 16B - Use of Marijuana for Medical Treatment|§ 7-1671.07. Health Occupations Boards review of medical marijuana authorized practitioner recommendations

(a) The Boards of Medicine, Nursing, and Dentistry" shall have the authority to review and audit the written authorized practitioner recommendations submitted to ABRA as part of the registration process and shall have the authority to discipline authorized practitioners under their licensing authority who act outside of the scope of this chapter. (b) The relevant licensing board shall audit the recommendations submitted by any authorized practitioner who provides more than 250 recommendations in any 12-month period to patients for the use of medical marijuana. (c) Submitting a false statement regarding a qualifying patient’s eligibility to participate in the Program on the form developed pursuant to § 7-1761.04(b)(2) shall be grounds for the revocation, suspension, or denial of an authorized practitioner's license, or the imposition of a civil fine pursuant to § 3-1205.14(c), or both, at the licensing board's discretion.  (Feb. 25, 2010, D.C. Law 13-315, § 8; as added July 27, 2010, D.C. Law 18-210, § 2, 57 DCR 4798; Feb. 18, 2017, D.C. Law 21-209, § 2(g), 63 DCR 15291; Dec. 3, 2020, D.C. Law 23-149, § 5012(f), 67 DCR 10493.)  Section References This section is referenced in § 3-1202.03 and § 7-1671.04.
DC Code § 7-1671.08 (2021)
2021 District of Columbia Code|Title 7 - Human Health Care and Safety|Chapter 16B - Use of Marijuana for Medical Treatment|§ 7-1671.08. Penalties

(a) Any person who manufactures, cultivates, possesses, administers, dispenses, distributes, or uses marijuana, or manufactures, possesses, distributes, or uses paraphernalia, in a manner not authorized by this chapter or the rules issued pursuant to § 7-1671.13 shall be subject to criminal prosecution and sanction under subchapter I of Chapter 11 of Title 48 [§ 48-1101 et seq.]. (b) Any person who makes a fraudulent representation to a law enforcement official of any fact or circumstance relating to the person’s manufacture, cultivation, possession, administration, dispensing, distribution, or use of medical marijuana, or manufacture, possession, distribution, or use of paraphernalia, to avoid arrest or prosecution shall be subject to a criminal fine not to exceed $1,000. The imposition of the fine shall be in addition to any other penalties that may otherwise apply for the making of a false statement or for the manufacture, cultivation, possession, administration, dispensing, distribution, or use of marijuana, or the manufacture, possession, distribution, or use of paraphernalia. (c) It shall be an affirmative defense to a criminal charge of possession or distribution of marijuana, or possession with intent to distribute marijuana, that the person charged with the offense is a person who: (1) Was in possession of medical marijuana only inside the qualifying patient’s residence or a medical treatment facility; (2) Only administered or assisted in administering the medical marijuana to the qualifying patient and only within the qualifying patient’s residence or at a permitted medical treatment facility; (3) Assisted the qualifying patient only when the caregiver was not reasonably available to provide assistance; and (4) Is 18 years of age or older. (d) Civil fines, penalties, and fees may be imposed as sanctions for any infraction of the provisions of this chapter, or any rules issued under § 7-1671.13, pursuant to Chapter 18 of Title 2 [§ 2-1801.01 et seq.]. Adjudication of any infraction of this chapter shall be pursuant to Chapter 18 of Title 2 [§ 2-1801.01 et seq.].  (Feb. 25, 2010, D.C. Law 13-315, § 9; as added July 27, 2010, D.C. Law 18-210, § 2, 57 DCR 4798.)
DC Code § 7-1671.08a (2021)
2021 District of Columbia Code|Title 7 - Human Health Care and Safety|Chapter 16B - Use of Marijuana for Medical Treatment|§ 7-1671.08a. Medical Cannabis Administration Fund

(a) There is established as a special fund the Medical Cannabis Administration Fund ("Fund"), which shall be administered by ABRA in accordance with subsection (c) of this section. (b) All funds received from medical cannabis licensing, permitting, and registration fees shall be deposited into the Fund. (c) Money deposited in the Fund shall be used by ABRA for the purpose of administering the medical marijuana program. (d)(1) The money deposited into the Fund shall not revert to the unrestricted fund balance of the General Fund of the District of Columbia at the end of a fiscal year, or at any other time. (2) Subject to authorization in an approved budget and financial plan, any funds appropriated in the Fund shall be continually available without regard to fiscal year limitation. (e) Funds received from penalties and fines imposed under § 7-1671.08 shall be credited to the unassigned fund balance of the General Fund of the District of Columbia.  (Feb. 25, 2010, D.C. Law 13-315, § 9a; as added Dec. 3, 2020, D.C. Law 23-149, § 5012(g), 67 DCR 10493.)
DC Code § 7-1671.09 (2021)
2021 District of Columbia Code|Title 7 - Human Health Care and Safety|Chapter 16B - Use of Marijuana for Medical Treatment|§ 7-1671.09. Medical Marijuana Advisory Committee

(a) The Mayor shall establish a Medical Marijuana Advisory Committee (“Committee”), which shall monitor: (1) Best practices in other states that allow the use of medical marijuana; (2) Scientific research on the medical use of marijuana; and (3) The effectiveness of the District’s medical marijuana program. (b) No later than January 1, 2012, the Committee shall submit a report to the Mayor and the Council recommending: (1) Whether the District of Columbia should allow qualifying patients and caregivers to cultivate medical marijuana; (2) How to implement and regulate cultivation of medical marijuana by qualifying patients and caregivers; and (3) Any other comments the Committee believes to be important.  (Feb. 25, 2010, D.C. Law 13-315, § 10; as added July 27, 2010, D.C. Law 18-210, § 2, 57 DCR 4798.)
DC Code § 7-1671.10 (2021)
2021 District of Columbia Code|Title 7 - Human Health Care and Safety|Chapter 16B - Use of Marijuana for Medical Treatment|§ 7-1671.10. Fees

(a) The Mayor is authorized to establish, by rulemaking, fees for the registration of caregivers, cultivation centers, dispensaries, testing laboratories, and qualifying patients and for the inspection and audit of cultivation centers, dispensaries, and testing laboratories. (b) Any of the fees collected pursuant to this chapter shall be applied first toward the cost of administering this chapter.  (Feb. 25, 2010, D.C. Law 13-315, § 11; as added July 27, 2010, D.C. Law 18-210, § 2, 57 DCR 4798; Feb. 18, 2017, D.C. Law 21-209, § 2(h), 63 DCR 15291.)
DC Code § 7-1671.11 (2021)
2021 District of Columbia Code|Title 7 - Human Health Care and Safety|Chapter 16B - Use of Marijuana for Medical Treatment|§ 7-1671.11. Liability

(a) No liability shall be imposed by virtue of this chapter upon any duly authorized District officer engaged in the enforcement of any law relating to controlled substances. (b) The District shall not be held liable for any deleterious outcomes from the use of medical marijuana, including the acts or omissions of any qualifying patient attributed to the use of medical marijuana.  (Feb. 25, 2010, D.C. Law 13-315, § 12; as added July 27, 2010, D.C. Law 18-210, § 2, 57 DCR 4798.)
DC Code § 7-1671.12 (2021)
2021 District of Columbia Code|Title 7 - Human Health Care and Safety|Chapter 16B - Use of Marijuana for Medical Treatment|§ 7-1671.12. Public and private insurance

Nothing in this chapter shall require a governmental, private, or any other health insurance provider or health care service plan to be liable for any claim for reimbursement for the use of medical marijuana.  (Feb. 25, 2010, D.C. Law 13-315, § 13; as added July 27, 2010, D.C. Law 18-210, § 2, 57 DCR 4798.)
DC Code § 7-1902 (2021)
2021 District of Columbia Code|Title 7 - Human Health Care and Safety|Chapter 19 - Adult Protective Services|§ 7-1902. Limitations on applicability. [Repealed]

Repealed.  (Mar. 14, 1985, D.C. Law 5-156, § 3, 32 DCR 13; Mar. 8, 2006, D.C. Law 16-67, § 2(b), 53 DCR 40.)  Prior Codifications 1981 Ed., § 6-2502. Editor's Notes Delayed application of Law 5-156: See Historical and Statutory Notes following § 7-1901.